Yolanda Serrano

Last updated
Yolanda Serrano
Born
Died(1993-10-21)October 21, 1993
Brooklyn, New York
NationalityPuerto Rican
Alma mater St. Francis College
EmployerADAPT
Known for HIV/AIDS activism, IV drug abusers activism
TitleExecutive Director
Term19881993
Children2
AwardsWoman of the Year 1988
Honoursone of Ms. magazine's Women of the Year 1988

Yolanda Serrano (died 1993) was a Puerto Rican-American drug counselor and HIV/AIDS activist. She received the National Organization for Women's Woman of the Year Award and was featured in Ms. magazine as one of the 1988 Women of the Year in 1988. [1] [2]

Contents

Early life and education

Serrano was born in Puerto Rico to Dhelia and Gaspar Serrano. [3] She had four siblings: Nora, Maria, Debbie, and Michael. She lived in Missouri and New Mexico before moving to Brooklyn in 1961. [4] She divorced her husband in 1975 and raised her two children by herself while paying for and completing university. [4]

Serrano graduated from St. Francis College in Brooklyn, New York. [3]

Career

Serrano worked for the Narcotics Bureau of the Brooklyn District Attorney, the Victim's Services Agency, and the State Division of Criminal Justice Services. She was Vice-President of the Hispanic AIDS Forum, secretary of the Latino Commission on AIDS, and a member of the Health and Human Services HIV Planning Council of New York. The government of Australia hired her as a consultant for their AIDS prevention programs. Over her career, she presented many papers in national and international HIV and AIDS conferences. [3]

She was a drug counselor working at Long Island College Hospital in 1981 when she began suspecting that her patients were dying from AIDS and AIDS-related conditions. She realized that little was being done by medical and governmental organizations to protect her clients or to prevent them from acquiring HIV, although they were catching and spreading the virus in mass, because they were seen as "undesirables" to the public. [1] [5] She was quoted, "They weren't organized the way gays were, nobody wanted to deal with them." [4]

ADAPT

Serrano began to focus her career on activism for IV drug users, and in 1983 she started working for Association for Drug Abuse Prevention and Treatment (ADAPT), an organization started by recovering drug addicts in 1979. [1] The organization relied on a small full-time staff and large number of volunteers for their initiatives. [6] [7]

She worked to expand outreach and educational programs for HIV/AIDS infected drug users, prostitutes, and Parolee Aftercare Relapse Prevention support groups. She assembled bleach kits to decontaminate syringes and distribute them, along with condoms, to IV drug users. She started setting up information tables in Williamsburg and Bushwick in Brooklyn, New York, East Harlem in Manhattan, and Hunts Point/Mott Haven in South Bronx. [1] Serrano said of her work:

I'm there to provide the addicts with information. It bothers me when they're sticking needles in their arms, but I feel protective. I live my work 24 hours. When I sleep, I dream about the people who died that day. [4]

One drug user impacted by Serrano said of her, "She's like the Avon Lady. At first you think 'the lady is nuts,' she's going into buildings the police won't go near, taking her life into her own hands." [4]

She coordinated the institution of the AIDS ward at Riker's Island Correctional Facility, where she and ADAPT began requesting the early release of prisoners who had AIDS, so that they could die peacefully in their own homes. [1]

In 1988, Serrano became the Executive Director of ADAPT [1] and defied laws banning the unauthorized use of needles and syringes by announcing that ADAPT would start a needle exchange in New York City. [8] It was the first needle exchange in the United States. In 1985, the Department of Health (DOH) under City Health Commissioner Dr. David J. Sencer had tried to start an exchange, but the State didn't support the initiative. [7] Serrano's announcement forced the issue and her pressure led to pilot needle-exchange program by the DOH. In 1990, after the election of Mayor David N. Dinkins, the city stopped the program but ADAPT carried on without support from lawmakers. [3] [6] [8] Later in 1988, she brought in over $2.5 million for its programs. ADAPT also became involved in federally, state, and city-funded research projects; it was the first community-based program to be funded by the Centers for Disease Control and Prevention to conduct an epidemiological research study on HIV/AIDS infection among crack cocaine users. [1]

Death and legacy

She died of cancer on October 21, 1993 in St. Vincent's Hospital and Medical Center at the age of 45. [3]

See also

Related Research Articles

<span class="mw-page-title-main">Harm reduction</span> Public health policies designed to lessen the negative consequences associated with human behavior

Harm reduction, or harm minimization, refers to a range of intentional practices and public health policies designed to lessen the negative social and/or physical consequences associated with various human behaviors, both legal and illegal. Harm reduction is used to decrease negative consequences of recreational drug use and sexual activity without requiring abstinence, recognizing that those unable or unwilling to stop can still make positive change to protect themselves and others.

<span class="mw-page-title-main">Needle and syringe programmes</span> Method of providing drug users with uninfected equipment

A needle and syringe programme (NSP), also known as needle exchange program (NEP), is a social service that allows injecting drug users (IDUs) to obtain clean and unused hypodermic needles and associated paraphernalia at little or no cost. It is based on the philosophy of harm reduction that attempts to reduce the risk factors for blood-borne diseases such as HIV/AIDS and hepatitis.

Needle sharing is the practice of intravenous drug-users by which a needle or syringe is shared by multiple individuals to administer intravenous drugs such as heroin, steroids, and hormones. This is a primary vector for blood-borne diseases which can be transmitted through blood. People who inject drugs (PWID) are at an increased risk for Hepatitis C (HCV) and HIV due to needle sharing practices. From 1933 to 1943, malaria was spread between users in the New York City area by this method. Afterwards, the use of quinine as a cutting agent in drug mixes became more common. Harm reduction efforts including safe disposal of needles, supervised injection sites, and public education may help bring awareness on safer needle sharing practices.

<span class="mw-page-title-main">Needlestick injury</span> Accidental puncture of skin causing contamination

A needlestick injury is the penetration of the skin by a hypodermic needle or other sharp object that has been in contact with blood, tissue or other body fluids before the exposure. Even though the acute physiological effects of a needlestick injury are generally negligible, these injuries can lead to transmission of blood-borne diseases, placing those exposed at increased risk of infection from disease-causing pathogens, such as the hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). Among healthcare workers and laboratory personnel worldwide, more than 25 blood-borne virus infections have been reported to have been caused by needlestick injuries. In addition to needlestick injuries, transmission of these viruses can also occur as a result of contamination of the mucous membranes, such as those of the eyes, with blood or body fluids, but needlestick injuries make up more than 80% of all percutaneous exposure incidents in the United States. Various other occupations are also at increased risk of needlestick injury, including law enforcement, laborers, tattoo artists, food preparers, and agricultural workers.

amfAR

amfAR, the Foundation for AIDS Research, known until 2005 as the American Foundation for AIDS Research, is an international nonprofit organization dedicated to the support of AIDS research, HIV prevention, treatment education, and the advocacy of AIDS-related public policy.

<span class="mw-page-title-main">Drug injection</span> Method of introducing a drug

Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle, which is pierced through the skin into the body. Intravenous therapy, a form of drug injection, is universally practiced in modernized medical care. As of 2004, there were 13.2 million people worldwide who self-administered injection drugs outside of medical supervision, of which 22% are from developed countries.

<span class="mw-page-title-main">HIV/AIDS in Yunnan</span>

The People's Republic of China's first reported AIDS case was identified in 1985 in a dying tourist. In 1989, the first indigenous cases were reported as an outbreak in 146 infected heroin users in Yunnan province, near China's southwest border.

<span class="mw-page-title-main">HIV/AIDS in Russia</span>

The situation with the spread of HIV/AIDS in Russia is described by some researchers as an epidemic. The first cases of human immunodeficiency virus infection were recorded in the USSR in 1985-1987. Patient zero is officially considered to be a military interpreter who worked in Tanzania in the early 1980s and was infected by a local man during sexual contact. After 1988—1989 Elista HIV outbreak, the disease became known to the general public and the first AIDS centers were established. In 1995-1996, the virus spread among injecting drug users (IDUs) and soon expanded throughout the country. By 2006, HIV had spread beyond the vulnerable IDU group, endangering their heterosexual partners and potentially the entire population.

<span class="mw-page-title-main">Drug policy of Portugal</span> Overview of the drug policy of Portugal

The drug policy of Portugal, informally called the "drug strategy", was put in place in 2000, and came into effect in July 2001. Its purpose was to reduce the number of new HIV/AIDS cases in the country, as it was estimated around half of new cases came from injection drug use.

HIV prevention refers to practices that aim to prevent the spread of the human immunodeficiency virus (HIV). HIV prevention practices may be undertaken by individuals to protect their own health and the health of those in their community, or may be instituted by governments and community-based organizations as public health policies.

Humanitarian Action is a non-governmental charitable organization based in St. Petersburg, Russia. Humanitarian Action carries out programs and outreach for HIV/AIDS prevention, and aiding street children, intravenous drug users, and sex workers. The program, founded in June 2001, grew out of the French NGO Doctors of the World, which created medical-social programs in Russia starting in 1995.

Low-threshold treatment programs are harm reduction-based health care centers targeted towards people who use substances. "Low-threshold" programs are programs that make minimal demands on the patient, offering services without attempting to control their intake of drugs, and providing counselling only if requested. Low-threshold programs may be contrasted with "high-threshold" programs, which require the user to accept a certain level of control and which demand that the patient accept counselling and cease all drug use as a precondition of support.

Prevention Point Philadelphia (PPP) was the first syringe exchange program in Philadelphia and Eastern Pennsylvania. Prevention Point Pittsburgh is the only other syringe exchange program in the state. The two organizations are not affiliated.

PULSE Foundation is a Bulgarian non-governmental organization, registered on July 7, 1999, under the name “Animus – Pernik”. Since the beginning of 2002, the organization continues its charitable activity under the name “PULSE” – “Positive Personal Skills in Society”. In 2015, PULSE Foundation operated with 19 full-time employees and over 40 youth volunteers.

New York City was affected by the AIDS epidemic of the 1980s more than any other U.S. city. The AIDS epidemic has been and continues to be highly localized due to a number of complex socio-cultural factors that affect the interaction of the populous communities that inhabit New York.

Beny Jene Primm was a prominent American physician, HIV/AIDS researcher, lecturer and advocate for public health policy reform.

Gerry Stimson is a British public health social scientist, emeritus professor at Imperial College London from 2004, and an honorary professor at the London School of Hygiene and Tropical Medicine from 2017. Stimson has over 220 scientific publications mainly on social and health aspects of illicit drug use, including HIV infection. He has sat on numerous editorial boards including AIDS, Addiction, and European Addiction Research, and with Tim Rhodes he was the co-editor-in-chief of the International Journal of Drug Policy from 2000 to 2016. He is one of the global leaders for research on and later advocacy for harm reduction.

<span class="mw-page-title-main">Odette Ferreira</span> Portuguese microbiologist and HIV researcher

Maria Odette Santos Ferreira was a Portuguese professor of microbiology who played an important role in research on HIV, through the identification of the HIV-2 virus in association with the Pasteur Institute of Paris. She was also the coordinator of the Portuguese programme to fight AIDS, overseeing the "Say no to a second-hand syringe" project, which resulted in the collection and exchange by pharmacies of 43 million used syringes between 1993 and 2008.

Richard Elovich is a social psychologist, writer, performance artist, and AIDS activist focusing on harm reduction and low-threshold approaches to drug treatment.

Harm reduction consists of a series of strategies aimed at reducing the negative impacts of drug use on users. It has been described as an alternative to the U.S.'s moral model and disease model of drug use and addiction. While the moral model treats drug use as a morally wrong action and the disease model treats it as a biological or genetic disease needing medical intervention, harm reduction takes a public health approach with a basis in pragmatism. Harm reduction provides an alternative to complete abstinence as a method for preventing and mitigating the negative consequences of drug use and addiction.

References

  1. 1 2 3 4 5 6 7 Pérez y González, María E. (2000). Puerto Ricans in the United States . Greenwood Publishing Group. pp.  100–101. ISBN   0313297487.
  2. Stevens, Darlene Gavron. "MS. SALUTES SIX WHO MADE A DIFFERENCE IN '88". chicagotribune.com. Retrieved 2018-10-23.
  3. 1 2 3 4 5 Sullivan, Ronald. "Yolanda Serrano, 45, Organizer Of Anti-AIDS Needle Exchanges". The New York Times. Retrieved 2018-10-23.
  4. 1 2 3 4 5 Carter, Zoe (1988-05-09). "ADAPT and Survive". New York Magazine.
  5. Bryon, Peg (June 9, 1990). "Help is hard to find for AIDS-endangered addicts". UPI. Retrieved 2018-10-23.
  6. 1 2 Chambré, Susan Maizel (2006). Fighting for Our Lives: New York's AIDS Community and the Politics of Disease. Rutgers University Press. ISBN   9780813538679.
  7. 1 2 Lambert, Bruce (1988-01-08). "Drug Group to Offer Free Needles To Combat AIDS in New York City". The New York Times. ISSN   0362-4331 . Retrieved 2019-10-21.
  8. 1 2 Lambert, Bruce (1988-01-09). "Reaction to Needles-for-Addicts Plan". The New York Times. ISSN   0362-4331 . Retrieved 2019-10-21.